Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Alkermes plc. | 88,843 | reported | 02 Mar 2026 | tx 471+15,371,578−9,738,213 |
| Epizyme, Inc. | 14,013 | reported | 29 May 2020 | tx 8+101,478 |
| COMBINATORX, INC | 12,500 | reported | 29 May 2008 | tx 4+37,500 |
| ACCELERON PHARMA INC | 7,500 | reported | 25 Jan 2019 | tx 14+113,750−75,000 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 79+475,414−341,974 |
| ALKERMES INC | 0 | reported | 16 Sept 2011 | tx 161+6,185,177−8,298,101 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 15 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 47.89 USD | 10b5-1 |
| 15 May 2026 | SALE | NEUROCRINE BIOSCIENCES INC | 15,000 | 157.65 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 0.00 USD | 10b5-1deriv |
| 02 Mar 2026 | GRANT_AWARD | Alkermes plc. | 88,843 | 0.00 USD | deriv |
| 05 Feb 2026 | TAX_WITHHOLDING | Alkermes plc. | 62,230 | 33.55 USD | |
| 05 Feb 2026 | GRANT_AWARD | Alkermes plc. | 149,580 | — | |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | Alkermes plc. | 293,921 | 0.00 USD | deriv |
| 06 Feb 2025 | TAX_WITHHOLDING | Alkermes plc. | 79,925 | 31.39 USD | |
| 06 Feb 2025 | GRANT_AWARD | Alkermes plc. | 190,640 | — | |
| 22 May 2024 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | |
| 17 May 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 2,100 | 141.84 USD | |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | deriv |
| 13 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 23,200 | 42.76 USD | |
| 13 Mar 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 23,200 | 140.33 USD | |
| 13 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 23,200 | 42.76 USD | deriv |
| 08 Mar 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 1,700 | 140.05 USD | |
| 08 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,700 | 42.76 USD | |
| 11 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 100 | 42.76 USD |